FDA's Janet Woodcock: the clinical trials system is 'broken'
The clinical trials system is “broken” and there needs to be new ways to collect and utilize patient data, Janet Woodcock, director of FDA’s Center …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
